Survodutide
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 88
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.